Category: Disclosures

[Disclosure] SK hynix (000660 / SKHY) – Other Disclosure (Notice of Reference Price for Interim (Quarterly) Ex-Dividend) / 2025-08-27

August 27, 2025August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary The reference price for SK hynix common stock due to quarterly ex-dividend was announced as KRW 260,000 (no change in reference price), effective August 28, 2025. 📊 [Key Disclosure Content & Key Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Ex-Dividend Implementation and…

Semiconductors, Disclosures

[Disclosure] LEENO Industrial (058470) – Investor Relations (IR) Holding / 2025-08-26

August 26, 2025August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary LEENO Industrial is participating in the ‘J.P.Morgan 10th Annual Asia Technology Tour’ IR event to present its business operations and conduct Q&A with institutional investors. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring IR Presentation Materials and Business Updates…

Disclosures, Semiconductors

[Disclosure] Hana Micron (067310) – Advance Notice of Unfaithful Disclosure Designation (Revocation of Disclosure) / 2025-08-26

August 26, 2025August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron has received an advance notice of designation as an unfaithful disclosure company under KOSDAQ market regulations following the withdrawal of its previous corporate split decision (revocation of disclosure). 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract (Voluntary Disclosure) / 2025-08-26

August 26, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has voluntarily disclosed the signing of a pharmaceutical contract manufacturing agreement with a European pharmaceutical company valued at approx. KRW 88.4B (USD 63,786,500). 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Contract Execution and Subsequent Official Disclosures…

Disclosures, Bio & Healthcare

[Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25

August 25, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering has announced that it will host a domestic Non-Deal Roadshow (NDR) in Seoul on August 26, 2025, for institutional investors and analysts to review H1 2025 financial results and business operations. 📊 [Key Disclosure Contents & Summary Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Semiconductors, Disclosures

[Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25

August 25, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering has announced that it will host a domestic Non-Deal Roadshow (NDR) in Seoul on August 27, 2025, for institutional investors and analysts to review H1 2025 financial results and business operations. 📊 [Key Disclosure Contents & Summary Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Semiconductors, Disclosures

[Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25

August 25, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering has announced that it will host a domestic Non-Deal Roadshow (NDR) in Seoul on August 25, 2025, for institutional investors and analysts to review H1 2025 financial results and business operations. 📊 [Key Disclosure Contents & Summary Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Disclosures, Semiconductors

[Disclosure] Samsung Biologics (207940) – (Correction) Decision on Corporate Spin-off / 2025-08-22

August 22, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a corrected filing for its corporate spin-off decision originally disclosed on May 22, 2025, updating the English name of the newly established entity and postponing the overall spin-off schedule—including the EGM date (Oct 17), spin-off date (Nov 1), trading suspension period, and…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – (Correction) Investor Caution Notice on Stock Futures and Options / 2025-08-22

August 22, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a corrected investor caution notice disclosing that, in accordance with the revised corporate spin-off schedule (August 22, 2025), the adjusted final trading day for its stock futures/options has been postponed to October 29, 2025, and the non-listing date for new contract months…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – (Correction) Execution of Single Sales or Supply Contract / 2025-08-21

August 21, 2025August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace filed a corrective disclosure for its 120mm self-propelled mortar follow-on mass production contract with the Defense Acquisition Program Administration (DAPA), adjusting the contract value from KRW 507.93B to KRW 507.47B and extending the contract end date by one year to December 31, 2026. 📊…

Disclosures, Defense